Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease

被引：0
|
作者：
Miquel Ensenyat-Mendez
Dennis Rünger
Javier I. J. Orozco
Julie Le
Jennifer L. Baker
Joanne Weidhaas
Diego M. Marzese
Maggie L. DiNome
机构：
[1] Institut d’Investigació Sanitària Illes Balears (IdISBa),Cancer Epigenetics Laboratory at the Cancer Cell Biology Group
[2] David Geffen School of Medicine at UCLA,Statistics Core, Department of Medicine
[3] Providence Saint John’s Health Center,Saint John’s Cancer Institute
[4] David Geffen School of Medicine at UCLA,Department of Surgery
[5] David Geffen School of Medicine at UCLA,Department of Radiation Oncology
[6] Duke University School of Medicine,Department of Surgery
来源：
Annals of Surgical Oncology | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4716 / 4724
页数：8
相关论文
共 50 条
  • [1] Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease
    Ensenyat-Mendez, Miquel
    Runger, Dennis
    Orozco, Javier I. J.
    Le, Julie
    Baker, Jennifer L.
    Weidhaas, Joanne
    Marzese, Diego M.
    DiNome, Maggie L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (08) : 4716 - 4724
  • [2] ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease
    Miquel Ensenyat-Mendez
    Dennis Rünger
    Javier I. J. Orozco
    Julie Le
    Jennifer L. Baker
    Joanne Weidhaas
    Diego M. Marzese
    Maggie L. DiNome
    [J]. Annals of Surgical Oncology, 2022, 29 : 4727 - 4727
  • [3] ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease
    Ensenyat-Mendez, Miquel
    Runger, Dennis
    Orozco, Javier I. J.
    Le, Julie
    Baker, Jennifer L.
    Weidhaas, Joanne
    Marzese, Diego M.
    DiNome, Maggie L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (8) : 4727 - 4727
  • [4] Factors Associated With Node-positive Disease in Estrogen Receptor-Positive Breast Cancer Patients
    Gallagher, Julia
    Elleson, Kelly M.
    Englander, Katherine
    Chintapally, Neha
    Sun, Weihong
    Whiting, Junmin
    Laronga, Christine
    Lee, Marie Catherine
    [J]. JOURNAL OF SURGICAL RESEARCH, 2024, 295 : 327 - 331
  • [5] Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancer
    Linda Ye
    Dennis Rünger
    Stephanie A. Angarita
    Joseph Hadaya
    Jennifer L. Baker
    Minna K. Lee
    Carlie K. Thompson
    Deanna J. Attai
    Maggie L. DiNome
    [J]. Breast Cancer Research and Treatment, 2022, 193 : 429 - 436
  • [6] Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancer
    Ye, Linda
    Runger, Dennis
    Angarita, Stephanie A.
    Hadaya, Joseph
    Baker, Jennifer L.
    Lee, Minna K.
    Thompson, Carlie K.
    Attai, Deanna J.
    DiNome, Maggie L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 193 (02) : 429 - 436
  • [7] Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer
    Tamirisa, Nina
    Lin, Heather
    Shen, Yu
    Shaitelman, Simona F.
    Sri Karuturi, Meghan
    Giordano, Sharon H.
    Babiera, Gildy
    Bedrosian, Isabelle
    [J]. JAMA ONCOLOGY, 2020, 6 (10) : 1548 - 1554
  • [8] Machine learning-based DNA methylation classifiers to predict pathologic nodal stage in breast cancer patients with clinically node positive disease
    DiNome, Maggie L.
    Ensenyat-Mendez, Miguel
    Orozco, Javier I. J.
    Runger, Dennis
    Baker, Jennifer L.
    Weidhaas, Joanne B.
    Marzese, Diego M.
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [9] Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer
    DeMichele, Angela
    Gray, Robert
    Horn, Michelle
    Chen, Jinbo
    Aplenc, Richard
    Vaughan, William P.
    Tallman, Martin S.
    [J]. CANCER RESEARCH, 2009, 69 (10) : 4184 - 4191
  • [10] DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy
    Hartmann, Oliver
    Spyratos, Frederique
    Harbeck, Nadia
    Dietrich, Dimo
    Fassbender, Anne
    Schmitt, Manfred
    Eppenberger-Castori, Serenella
    Vuaroqueaux, Vincent
    Lerebours, Florence
    Welzel, Katrin
    Maier, Sabine
    Plum, Achim
    Niemann, Stephan
    Foekens, John A.
    Lesche, Ralf
    Martens, John W. M.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (01) : 315 - 323
12345